Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells

Journal of Immunology

Volumn 166, Issue 8, 2001, Pages 5236-5244

  Rea, D ^a   Havenga, M J E ^a   Van den Assem, M ^a   Sutmuller, R P M ^a   Lemckert, A ^a   Hoeben, R C ^a   Bout, A ^a   Melief, C J M ^a   Offringa, R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS 5; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DNA MODIFICATION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MONOCYTE; PRIORITY JOURNAL; TRANSGENE;

EID: 0035871784     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.8.5236     Document Type: Article

References (52)

1. Immunobiology of dendritic cells
2. Efficient presentation of soluble antigens by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor and downregulated by tumor necrosis factor α
3. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products
4. CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
5. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
6. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells
7. Maturation, activation and protection of dendritic cells induced by double stranded RNA
8. Natural adjuvants: Endogenous activators of dendritic cells
9. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
10. Activation of dendritic cells through CD40 cross-linking
11. Ligation of CD40 on dendritic cells triggers the production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T-help via APC activation
12. Therapy of murine tumors with tumor-peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines
13. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity
14. Dendritic cells retroviralty transduced with a model antigen gene are therapeutically effective against established pulmonary metastases
15. Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic cells and carcinoma cells
16. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
17. Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
18. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids
19. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens
20. Dendritic cells in cancer immunotherapy
21. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells
22. Adenoviruses activate human dendritic cells without polarization toward a T helper type 1-inducing subset
23. Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively
24. Human adenovirus serotype 3 and 5 bind to two different cellular receptors via the fiber head domain
25. 5 promote adenovirus internalization but not virus attachment
26. Multiple adenovirus serotypes use αv integrins for infection
27. Isolation of a common receptor for coxsackie B viruses and adenovirus 2 and 5
28. Adenovirus type 5 fiber knob binds to MHC class I α2 domain at the surface of human epithelial and B lymphoblastoid cells
29. The human HLA-A*0201 allele, expressed in hamster cells, is not a high-affinity receptor for adenovirus type 5 fiber
30. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells
31. The coxsackie-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E and F
32. Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector
33. + T cells in patients with melanoma
34. + T-cell responses to dendritic cells genetically engineered to express the MART-1/Melan-A gene
35. Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus
36. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses
37. Detection of wild-type contamination in a recombinant adenoviral preparation by PCR
38. Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles
39. Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: Influence of mismatches on quantification
40. Accurate estimation of transduction efficiency necessitates a multiplex real-time PCR
41. Comparative analysis of adenovirus fiber-cell interaction: Adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment
42. Type I IFNs enhance the terminal differentiation of dendritic cells
43. Adenoviral transduction of human clinical grade immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity
44. Recombinant adenovirus induces maturation of dendritic cells via an NF-κB-dependent pathway
45. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating lymphocytes associated with in vivo tumor regression
46. DNA-based immunization by in vivo transfection of dendritic cells
47. Adenovirus vector pseudotyping in fiber-expressing cell lines: Improved transduction of Epstein-Barr virus-transformed B cells
48. Adenovirus type 11p and 35p show high binding efficiencies for committed hematopoietic cell lines and are infective to these cell lines
49. + cells by a retargeted adenovirus vector
50. Fiber swap between adenovirus subgroup B and C alters intracellular trafficking of adenovirus gene transfer vectors
51. Dendritic cell survival and maturation are regulated by different signaling pathways
52. Cross-linking CD40 on B cells rapidly activates nuclear factor NFκB